Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered products on a temporary basis: XYLOCAINE 2% with ADRENALINE 1-200000 VIAL pack of 10x20ml (ASPEN Canada) This products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st July 2022. Please contact us for more information. Link to Dear Health Care P

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered Gemfibrozil products on a temporary basis: Gemfibrozil Tablets USP 600mg (Cipla USA) This products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st July 2022. Please contact us for more information. Link to Dear Health Care Professional Label

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporary basis: RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled syringe (Roche Germany) RoActemra tocilizumab 162mg/0.9mL solution for injection in pre-filled pen (Roche Germany) These products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 1

Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporary basis: RoActemra tocilizumab 80 mg/4 mL concentrate for solution for infusion (Roche Germany) RoActemra tocilizumab 200 mg/10mL concentrate for solution for infusion (Roche Germany) RoActemra tocilizumab 400 mg/20mL concentrate for solution for infusion (Roche Germany) These products are NOT registered in Australia and supply is authorised under an ex

​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th June 2021. Import and supply approved until: 31st August 2021 (now extended) ​ Imipramine 25mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 25mg not available. This shortage is expected to continue until Mid 2021. ​ Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 25 MG 100 TABLETS (LEADING PHARMA LLC) S19a​ Stock availability:

Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 10mg Tablets until 15th October 2021. Import and supply approved until: 15th October 2021 ​ Imipramine 10mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 10mg not available. This shortage is expected to continue until 31st July 2021. ​ Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 10 MG 100 TABLETS (LEADING PHARMA LLC) S19a​ PBS Listing: TBC ​ Order

If this was written in the USA or European Markets then the title would only be Early Access Program as those markets would be targeted by any Pharmaceutical Company! However many companies may not plan Australia in their global plan or plan Australia at a later stage in their product life cycle. The Australian market is around 25 million population with high global health standards, products in public hospitals are paid for by the hospital budgets and clinical needs of pati

​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020. ​ Bleomycin Injection is currently experiencing a shortage of supply in Australia. ​ Product: Bleomycin Injection 15 Units S19a ​ Stock availability: Stock is available now at Wholesalers Nationally. ​ Ordering Orders can be placed via Wholesalers Symbion and Central Healthcare Services (CHS) via the below PDE numbers. ​ Symbion PDE: 629103 CHS PDE: BLE